奥曲肽
肢端肥大症
医学
内科学
内分泌学
药品
药理学
生长激素
生长抑素
激素
作者
Steven W. J. Lamberts,Leo J. Hofland
出处
期刊:European journal of endocrinology
[Bioscientifica]
日期:2019-08-09
卷期号:181 (5): R173-R183
被引量:78
摘要
Octreotide remains 40 years after its development a drug, which is commonly used in the treatment of acromegaly and GEP-NETs. Very little innovation that competes with this drug occurred over this period. This review discusses several aspects of 40 years of clinical use of octreotide, including the application of radiolabeled forms of the peptide.
科研通智能强力驱动
Strongly Powered by AbleSci AI